Clinical Trial Update: Reducing Risk and Trauma-Related Stress in Persons Living With HIV [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating approaches to reduce risk and trauma-related stress in people living with HIV has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Post-traumatic Stress Disorder

Snippet

Sponsor: Stanford University | Conditions: HIV, PTSD | Phase 1, Phase 2 | Status: TERMINATED